4.74% -1.31

Amylyx Pharmaceuticals Inc (AMLX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Selling, General, and Administrative	35.60% 21.93	16.17	15.39	16.17	15.64
Costs And Expenses	4.37% 45.69	43.78	36.60	36.03	42.86
Operating Income/Loss	4.37% -45.69	-43.78	-36.60	-36.03	-42.86
Nonoperating Income/Loss	9.02% 2.27	2.495	3.652	1.641	1.414
Net Income/Loss	5.18% -43.42	-41.28	-33.00	-34.39	-41.44
Basic Average Shares	0.57% 111.20	110.56	5.1481	93.33	89.14
Diluted Average Shares	0.57% 111.20	110.56	5.1481	93.33	89.14
Basic Earnings Per Share	5.41% -0.39	-0.37	-0.28	-0.37	-0.46
Diluted Earnings Per Share	5.41% -0.39	-0.37	-0.28	-0.37	-0.46

LQDA

$34.35

1.24%

INDV

$32.45

3.48%

HCM

$14.05

0.79%

PBH

$49.92

1.46%

BHC

$6.30

0.16%

PRGO

$16.63

0.91%